Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03482297 · ClinicalTrials.gov registry record · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
A Phase 1 study of Multiple System Atrophy and Orthostatic Hypotension, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT03482297 is a Phase 1 study of Multiple System Atrophy and Orthostatic Hypotension that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 31 participants, below the 267-participant average among 30 other Multiple System Atrophy trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03482297, a Phase 1 study of Multiple System Atrophy and Orthostatic Hypotension, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
The automated inflatable abdominal binder is an investigational device for the treatment of orthostatic hypotension (low blood pressure on standing) in patients with autonomic failure. The purpose of this study is to determine safety and effectiveness of the automated abdominal binder in improving orthostatic tolerance in these patients.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Midodrine
- DEVICE automated abdominal binder
- DEVICE Sham binder
Study Locations (1)
Tennessee
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2026-12-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03482297
The ClinicalTrials.gov registry entry for NCT03482297 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 30 other Multiple System Atrophy trials with a reported enrollment target (88% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Multiple System Atrophy appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT03482297 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT03482297 about?
NCT03482297 is a clinical study titled "Automated Abdominal Binder for Orthostatic Hypotension". The automated inflatable abdominal binder is an investigational device for the treatment of orthostatic hypotension (low blood pressure on standing) in patients with autonomic failure. The purpose of this study is to determine safety and effectiveness of the automated abdominal binder in improving o...
What is the current status of trial NCT03482297?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 31 participants. The study started on 2018-03-01. Estimated completion is 2026-12-01.
What conditions does trial NCT03482297 study?
This clinical trial studies the following conditions: Multiple System Atrophy, Orthostatic Hypotension, Autonomic Failure, Pure Autonomic Failure.
What interventions are being tested in trial NCT03482297?
The interventions under investigation include: Placebo (DRUG), Midodrine (DRUG), automated abdominal binder (DEVICE), Sham binder (DEVICE).
Who is sponsoring clinical trial NCT03482297?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03482297 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple System Atrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
[18F]F-DOPA Imaging in Patients With Autonomic Failure
RECRUITING · Phase 1
-
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
RECRUITING · Phase 1
-
Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies
RECRUITING · Phase 1
-
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
RECRUITING · Phase 1
-
GDNF Gene Therapy for Multiple System Atrophy
ACTIVE NOT RECRUITING · Phase 1
-
Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic
ACTIVE NOT RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.